Literature DB >> 20694488

Further evidence that methylenetetrahydrofolate reductase A1298C polymorphism is a risk factor for schizophrenia.

Chen Zhang1, Bin Xie, Yasong Du, Wenhong Cheng, Yiru Fang, Shunying Yu.   

Abstract

Previous work suggests that the methylenetetrahydrofolate reductase gene (MTHFR) functional polymorphism A1298C may be a risk factor for schizophrenia. In this study, the genetic association between the MTHFR A1298C polymorphism and schizophrenia was investigated in 379 patients with schizophrenia and 380 age- and sex-matched controls subjects. The results showed an association between the 1298C allele and the disorder (OR 1.39, 95% confidence interval 1.08-1.79). This provides further evidence that the MTHFR A1298C polymorphism may play a role in conferring risk for schizophrenia in the Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694488     DOI: 10.1007/s00702-010-0442-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  15 in total

1.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.

Authors:  Yong Yong Shi; Lin He
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

2.  Elevated prenatal homocysteine levels as a risk factor for schizophrenia.

Authors:  Alan S Brown; Teodoro Bottiglieri; Catherine A Schaefer; Charles P Quesenberry; Liyan Liu; Michaeline Bresnahan; Ezra S Susser
Journal:  Arch Gen Psychiatry       Date:  2007-01

3.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

4.  Homocysteine levels in adolescent schizophrenia patients.

Authors:  G Adler Nevo; S Meged; B A Sela; A Hanoch-Levi; R Hershko; A Weizman
Journal:  Eur Neuropsychopharmacol       Date:  2006-04-27       Impact factor: 4.600

Review 5.  Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis.

Authors:  J W Muntjewerff; R S Kahn; H J Blom; M den Heijer
Journal:  Mol Psychiatry       Date:  2006-02       Impact factor: 15.992

Review 6.  The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.

Authors:  Dennis R Grayson; Ying Chen; Erminio Costa; Erbo Dong; Alessandro Guidotti; Marija Kundakovic; Rajiv P Sharma
Journal:  Pharmacol Ther       Date:  2006-03-30       Impact factor: 12.310

7.  Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor.

Authors:  S A Lipton; W K Kim; Y B Choi; S Kumar; D M D'Emilia; P V Rayudu; D R Arnelle; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

8.  MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians.

Authors:  Suchita Markan; Meenakshi Sachdeva; Badan Singh Sehrawat; Savita Kumari; Sanjay Jain; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2007-03-01       Impact factor: 3.396

9.  Influence of maternal MTHFR A1298C polymorphism on the risk in offspring of schizophrenia.

Authors:  Chen Zhang; Bin Xie; Yiru Fang; Wenhong Cheng; Yasong Du; Dongxiang Wang; Shunying Yu
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

10.  Genetic associations with schizophrenia: meta-analyses of 12 candidate genes.

Authors:  Jiajun Shi; Elliot S Gershon; Chunyu Liu
Journal:  Schizophr Res       Date:  2008-08-20       Impact factor: 4.939

View more
  7 in total

1.  APOE, MTHFR, LDLR and ACE polymorphisms among Angami and Lotha Naga populations of Nagaland, India.

Authors:  Benrithung Murry; Neikethono Vakha; Nongthombam Achoubi; M P Sachdeva; K N Saraswathy
Journal:  J Community Health       Date:  2011-12

2.  Age Matters: an Atypical Association Between Polymorphism of MTHFR and Clinical Phenotypes in Children with Schizophrenia.

Authors:  Lin Wan; Yuhong Li; Yuming Zhou; Rena Li; Yi Zheng
Journal:  J Mol Neurosci       Date:  2019-07-13       Impact factor: 3.444

3.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis.

Authors:  Cai-Yun Hu; Zhen-Zhong Qian; Feng-Feng Gong; Shan-Shan Lu; Fang Feng; Yi-Le Wu; Hui-Yun Yang; Ye-Huan Sun
Journal:  J Neural Transm (Vienna)       Date:  2014-06-18       Impact factor: 3.575

4.  No association of functional polymorphisms in methlylenetetrahydrofolate reductase and the risk and minor physical anomalies of schizophrenia in Korean population.

Authors:  Su-Gyeong Kim; Joo Yun Song; Eun-Jeong Joo; Seong Hoon Jeong; Se Hyun Kim; Kyu Young Lee; Nam Young Lee; Yong Min Ahn; Yong Sik Kim; Myoung-Sun Roh
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

Review 5.  Methylenetetrahydrofolate reductase and psychiatric diseases.

Authors:  Lin Wan; Yuhong Li; Zhengrong Zhang; Zuoli Sun; Yi He; Rena Li
Journal:  Transl Psychiatry       Date:  2018-11-05       Impact factor: 6.222

6.  Association between variants of MTHFR genes and psychiatric disorders: A meta-analysis.

Authors:  Yu-Xin Zhang; Lu-Ping Yang; Cong Gai; Cui-Cui Cheng; Zhen-Yu Guo; Hong-Mei Sun; Die Hu
Journal:  Front Psychiatry       Date:  2022-08-18       Impact factor: 5.435

Review 7.  Methylenetetrahydrofolate reductase A1298C genetic variant& risk of schizophrenia: A meta-analysis.

Authors:  Vandana Rai; Upendra Yadav; Pradeep Kumar; Sushil K Yadav; Sanjay Gupta
Journal:  Indian J Med Res       Date:  2017-04       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.